Department of Neurology, University of Lübeck, Lübeck, Germany.
Mov Disord. 2009 Oct 30;24(14):2042-58. doi: 10.1002/mds.22675.
In the past decade, a number of genetic causes of parkinsonism have been identified. As a consequence, clinicians have to consider an increasing range of differential diagnoses when confronted with a patient with parkinsonism with a positive family history. While well-established monogenic forms with PARK acronyms have been reviewed extensively, less emphasis has been placed on other inherited conditions that may also present with signs of parkinsonism or even mimic idiopathic Parkinson's disease clinically. In this review, we focus on three different scenarios in patients with an overall early age of onset of parkinsonism: (i) atypical features in patients with mutations in one of the "PARK" genes; (ii) classical parkinsonism due to mutations in "other than-PARK" genes or yet other genes where parkinsonism may be a well-recognized, concomitant, or even an isolated feature; (iii) atypical parkinsonism in other genetic disorders which are, however, typically characterized by features other than parkinsonism. Atypical features in patients from Group I include, for example, a slower disease course (PARK2, PARK6, PARK7) or dementia (PARK1/4, PARK14). Conditions in Group II have been designated by a DYT or SCA acronym (for example, DYT5 or SCA3) and also include patients with heterozygous GBA mutations, mitochondrial gene mutations. Group III comprises mutations in the FMR1, MAPT, GRN, ATP7B, PANK2, FBXO7, CHAC, FTL1, Huntingtin, JPH3 genes, and a number of even rarer, miscellaneous conditions.
在过去的十年中,已经确定了许多帕金森病的遗传原因。因此,当临床医生面对有阳性家族史的帕金森病患者时,必须考虑越来越多的鉴别诊断。虽然具有 PARK 首字母缩写词的既定单基因形式已被广泛研究,但对其他可能也表现出帕金森病体征甚至在临床上模拟特发性帕金森病的遗传疾病的关注较少。在这篇综述中,我们关注帕金森病总体发病年龄较早的患者的三种不同情况:(i)具有“PARK”基因之一突变的患者中的非典型特征;(ii)由于“非-PARK”基因或其他可能帕金森病是公认的、伴随的甚至是孤立的特征的基因突变引起的经典帕金森病;(iii)其他遗传疾病中的非典型帕金森病,然而,这些疾病通常以帕金森病以外的特征为特征。来自第一组的患者的非典型特征包括例如疾病进程较慢(PARK2、PARK6、PARK7)或痴呆(PARK1/4、PARK14)。第二组疾病以 DYT 或 SCA 首字母缩写词命名(例如,DYT5 或 SCA3),还包括杂合 GBA 突变、线粒体基因突变的患者。第三组包括 FMR1、MAPT、GRN、ATP7B、PANK2、FBXO7、CHAC、FTL1、亨廷顿病、JPH3 基因突变以及许多更罕见的、各种其他疾病。